Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1968 May;2(5):449–455. doi: 10.1128/jvi.2.5.449-455.1968

Soluble Antigens of Vaccinia-infected Mammalian Cells

III. Relation of “Early” and “Late” Proteins to Virus Structure

Gary H Cohen 1,1, Wesley C Wilcox 1
PMCID: PMC375633  PMID: 5688397

Abstract

The structural proteins of vaccinia virus can be divided into two classes on the basis of their times of synthesis in the infected cell. The production of one of these classes of proteins begins prior to the onset of viral deoxyribonucleic acid (DNA) replication. These are referred to as “early” proteins. Synthesis of the second class of structural proteins follows the onset of viral DNA replication; hence, the term “late” proteins for this class. We are able, by immunological procedures, to identify three “early” virus-structural proteins. These materials, when incorporated into virions, appear to be associated with the “core” of the virion and do not elicit production of virus-neutralizing antibody. It would seem, therefore, that those virus-structural proteins synthesized early in the course of infection act as internal components of the virion. The “late” proteins may be subdivided into two groups on the basis of certain physical properties and molecular weight differences. The first of these groups, comprised of at least two proteins, corresponds to the classical LS antigens and elicits production of neutralizing antibodies. These proteins, when incorporated into virions, are found only in the outer (“coat”) fraction of the virion. The second group of “late” antigens, also comprised of two proteins, termed the G antigens, do not elicit synthesis of neutralizing antibody. One of these proteins is associated with the virus “core”; the other is found in the “coat” fraction of the virion and appears to occupy an intermediary, subsurface position. Procedures suitable for the isolation of the G antigens are described, in addition to the partial characterization of these antigens.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen G. H., Wilcox W. C. Soluble antigens of vaccinia-infected mammalian cells. I. Separation of virus-induced soluble antigens into two classes on the basis of physical characteristics. J Bacteriol. 1966 Sep;92(3):676–686. doi: 10.1128/jb.92.3.676-686.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Easterbrook K. B. Controlled degradation of vaccinia virions in vitro: an electron microscopic study. J Ultrastruct Res. 1966 Mar;14(5):484–496. doi: 10.1016/s0022-5320(66)80077-1. [DOI] [PubMed] [Google Scholar]
  3. JOKLIK W. K. The preparation and characteristics of highly purified radioactively labelled poxvirus. Biochim Biophys Acta. 1962 Aug 20;61:290–301. doi: 10.1016/0926-6550(62)90091-9. [DOI] [PubMed] [Google Scholar]
  4. Jungwirth C., Joklik W. K. Studies on "early" enzymes in HeLa cells infected with vaccinia virus. Virology. 1965 Sep;27(1):80–93. doi: 10.1016/0042-6822(65)90145-5. [DOI] [PubMed] [Google Scholar]
  5. KIT S., DUBBS D. R. PROPERTIES OF DEOXYTHYMIDINE KINASE PARTIALLY PURIFIED FROM NONINFECTED MOUSE FIBROBLAST CELLS. Virology. 1965 May;26:16–27. doi: 10.1016/0042-6822(65)90021-8. [DOI] [PubMed] [Google Scholar]
  6. LOH P. C., PAYNE F. E. EFFECT OF 5-FLUORO-2'-DEOXYURIDINE ON THE SYNTHESIS OF VACCINIA VIRUS. Virology. 1965 Apr;25:575–584. doi: 10.1016/0042-6822(65)90085-1. [DOI] [PubMed] [Google Scholar]
  7. MCAUSLAN B. R. THE INDUCTION AND REPRESSION OF THYMIDINE KINASE IN THE POXVIRUS-INFECTED HELA CELL. Virology. 1963 Nov;21:383–389. doi: 10.1016/0042-6822(63)90199-5. [DOI] [PubMed] [Google Scholar]
  8. Magee W. E., Miller O. V. Immunological evidence for the appearance of a new DNA-polymerase in cells infected with vaccinia virus. Virology. 1967 Jan;31(1):64–69. doi: 10.1016/0042-6822(67)90008-6. [DOI] [PubMed] [Google Scholar]
  9. Marquardt J., Falsen E., Lycke E. Isolation of vaccinial immunoprecipitinogens. Arch Gesamte Virusforsch. 1967;20(1):109–118. doi: 10.1007/BF01245774. [DOI] [PubMed] [Google Scholar]
  10. Marquardt J., Holm S. E., Lycke E. Immunoprecipitating factors of vaccinia virus. Virology. 1965 Oct;27(2):170–178. doi: 10.1016/0042-6822(65)90156-x. [DOI] [PubMed] [Google Scholar]
  11. Oda K. I., Joklik W. K. Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA. J Mol Biol. 1967 Aug 14;27(3):395–419. doi: 10.1016/0022-2836(67)90047-2. [DOI] [PubMed] [Google Scholar]
  12. SALZMAN N. P., SHATKIN A. J., SEBRING E. D. Viral protein and DNA synthesis in vaccinia virus-infected HeLacell cultures. Virology. 1963 Apr;19:542–550. doi: 10.1016/0042-6822(63)90049-7. [DOI] [PubMed] [Google Scholar]
  13. Salzman N. P., Sebring E. D. Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. J Virol. 1967 Feb;1(1):16–23. doi: 10.1128/jvi.1.1.16-23.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Salzman N. P., Shatkin A. J., Sebring E. D. The use of metabolic inhibitors in studies on the mode of replication of vaccinia virus. Ann N Y Acad Sci. 1965 Jul 30;130(1):240–248. doi: 10.1111/j.1749-6632.1965.tb12557.x. [DOI] [PubMed] [Google Scholar]
  15. WESTWOOD J. C., ZWARTOUW H. T., APPLEYARD G., TITMUSS D. H. COMPARISON OF THE SOLUBLE ANTIGENS AND VIRUS PARTICLE ANTIGENS OF VACCINIA VIRUS. J Gen Microbiol. 1965 Jan;38:47–53. doi: 10.1099/00221287-38-1-47. [DOI] [PubMed] [Google Scholar]
  16. WOODROOFE G. M., FENNER F. Serological relationships within the poxvirus group: an antigen common to all members of the group. Virology. 1962 Mar;16:334–341. doi: 10.1016/0042-6822(62)90255-6. [DOI] [PubMed] [Google Scholar]
  17. Wilcox W. C., Cohen G. H. Soluble antigens of vaccinia-infected mammalian cells. II. Time course of synthesis of soluble antigens and virus structural proteins. J Virol. 1967 Jun;1(3):500–508. doi: 10.1128/jvi.1.3.500-508.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES